Jul 29, 2021 / 12:00PM GMT
Antje Witte - UCB SA - Head of IR
Good day. This is UCB. We welcome you to this call. We hope this finds you well. We appreciate your participation in today's UCB's analyst and investors call. On the next slide, we have our usual disclaimer and safe harbor statement, which we kindly ask to study and to read. And as noted in our disclosures on these contingencies, our guidance is subject to legal and regulatory risks and uncertainties.
And with this, I'd like to introduce you to the plan of today. So you will -- we will have Jean-Christophe Tellier, our CEO, to give you an overview on our purpose and an overview of the first half. Emmanuel Caeymaex is going, what you're waiting for, for sure, talk to you about BIMZELX and our readiness for launch. He will be followed by our Chief Medical Officer, Iris Löw-Friedrich, who is going to bring up to you the pipeline and the updates. And of course, Sandrine Dufour, our CFO, will guide you through our P&L and the financials of the first half. Last but not least, Jean-Christophe will close the call with where we are heading into the future.
Half Year 2021 UCB SA Earnings Call Transcript
Feb 15, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers